Cann Group Limited (CAN:ASX)

62.0¢

right-arrow Created with Sketch. -0.005 (-0.8%)
MCAP $170.9M
Last trade 15.08pm 26/02/2021 20mins delayed

Latest Announcements

22/02/2021 Price SensitivePSCANCann Group Limited
22/02/2021 Price SensitivePSCANCann Group Limited
22/02/2021 Price SensitivePSCANCann Group Limited
19/02/2021CANCann Group Limited
19/02/2021CANCann Group Limited
19/02/2021CANCann Group Limited
19/02/2021CANCann Group Limited
18/02/2021CANCann Group Limited

Company Overview

Cann Group Limited is an Australia-based company, which is engaged in the cultivation of cannabis for human medicinal and research purposes. The Company has facilities to cultivate medicinal cannabis. It also focuses on manufacturing medicinal cannabis products. It focuses on developing and supplying cannabis, cannabis resin and medicinal cannabis products into the Australian market. It also focuses on supplying to overseas markets. The Company has a cannabis research license and cannabis cultivation license. The cannabis cultivation license allows the Company to produce Australian grown material that can be prescribed for patient use. It has research and development, and cultivation facilities in Australia. It focuses on plant genetics; breeding; cultivation; extraction; analysis and production techniques to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions.

CAN in the news

Search Previous Announcements